/FOGCF

FOGCF Stock - Avisa Diagnostics Inc.

Q: What is the analyst price target for FOGCF?

Analyst price target information is not currently available for FOGCF.

Q: What is FOGCF's market cap?

Market capitalization information is not currently available for FOGCF.

Healthcare|Medical - Pharmaceuticals|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for FOGCF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-1.71

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2020	FY2019
Revenue	$277,830	$858,359
Gross Profit	$129,281	$-1,944,803
Gross Margin	46.5%	-226.6%
Operating Income	$-900,655	$-2,731,999
Net Income	$-715,762	$-4,133,893
Net Margin	-257.6%	-481.6%
EPS	$-0.14	$-0.86

Company Overview

Avisa Diagnostics Inc. operates a clinical-stage medical device company. It is developing the Avisa BreathTest, a novel drug/device biomarker technology platform that enables the ultra-rapid detection of virulent bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its proprietary drug substrates. The company offers clinical proof-of-concept through trials in cystic fibrosis, tuberculosis, and communityacquired pneumonia. It focuses on pivotal trials in Post-COVID-19 bronchiectasis and ventilator-associated pneumonia. Avisa Diagnostics Inc. is based in Santa Fe, New Mexico.

Visit Website

Frequently Asked Questions about FOGCF

What is FOGCF's current stock price?

Avisa Diagnostics Inc. (FOGCF) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for FOGCF?

No analyst price targets are currently available for this stock.

What sector is Avisa Diagnostics Inc. in?

Avisa Diagnostics Inc. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the OTC exchange.

What is FOGCF's market cap?

Avisa Diagnostics Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does FOGCF pay dividends?

No, Avisa Diagnostics Inc. does not currently pay a dividend to shareholders.